Addiction Research Group
The mission of this research group is to understand the neurobiology of addiction and evaluate addiction prevention, treatment, and harm reduction strategies. Members of this group share collective expertise from bench to clinic to community. The key goal is to reduce the addiction rate and addiction-associated morbidity and mortality by understanding the genetic underpinnings of addiction vulnerability, improving the quality of clinical care, and investigating the brain and psychosocial mechanisms that mediate each stage of the addiction cycle.
Dr. Ali Rezai, executive chair of the West Virginia University Rockefeller Neuroscience Institute, lays out his bold, new vision for neuroscience at WVU. Joining Dr. Rezai are WVU President Gorden Gee, Albert Wright, president and chief executive officer of the West Virginia University Health System, and Clay Marsh, MD, vice president and executive dean for Health Science at WVU.
Research drives patient care at any large academic medical center. As stroke treatment has dramatically evolved in the past decade, WVU Medicine’s neurointerventionists have emerged as national leaders in their relatively new field. Here, Ansaar Rai, MD, WVU Medicine Radiology vice chair of clinical operations, discusses the past and present of stroke treatment.
Neurosurgeons treat their patients through the use of a delicate, targeted procedure; the best neurosurgeons are skilled at several. WVU Medicine neurosurgeon Robert A. Marsh, MD, PhD, says his best approach is unique to each patient, and considers wishes as well as needs.